Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Lee

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Clinical Genitourinary Cancer|July 23, 2023
Case Series of Men with the Germline APC I1307K variant and Treatment-Emergent Neuroendocrine Prostate CancerMinas P Economides, Mari Nakazawa, Jonathan W Lee, et al.
International Journal of Molecular Sciences|July 2, 2021
Pioglitazone Ameliorates Lipopolysaccharide-Induced Behavioral Impairment, Brain Inflammation, White Matter Injury and Mitochondrial Dysfunction in Neonatal RatsJiann-Horng Yeh, Kuo-Ching Wang, Asuka Kaizaki, et al.
Neurochemistry International|January 29, 2020
Interleukin-1 receptor antagonist ameliorates the pain hypersensitivity, spinal inflammation and oxidative stress induced by systemic lipopolysaccharide in neonatal ratsCheng-Ta Hsieh, Yih-Jing Lee, Jonathan W Lee, et al.
Current Research in Neurobiology|January 18, 2024
Intranasal insulin attenuates hypoxia-ischemia-induced short-term sensorimotor behavioral disturbances, neuronal apoptosis, and brain damage in neonatal ratsChirag P Talati, Jonathan W Lee, Silu Lu, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2014
Nephron Deficiency and Predisposition to Renal Injury in a Novel One-Kidney Genetic ModelXuexiang Wang, Ashley C Johnson, Jan M Williams, et al.
Neurochemistry International|April 19, 2024
Neonatal brain inflammation enhances methamphetamine-induced reinstated behavioral sensitization in adult rats analyzed with explainable machine learningKuo-Ching Wang, Norma B Ojeda, Haifeng Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2020
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline <i>BRCA/PALB2</i> MutationEileen M O'Reilly, Jonathan W Lee, Mark Zalupski, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2017
Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinomaMaeve A Lowery, David P Kelsen, Marinela Capanu, et al.
EMBO Molecular Medicine|July 6, 2019
Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistanceEliana Mc Tacconi, Sophie Badie, Giuliana De Gregoriis, et al.
Cancer|January 17, 2018
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinomaEileen M O'Reilly, Jonathan W Lee, Maeve A Lowery, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinical Genitourinary Cancer|July 23, 2023
Case Series of Men with the Germline APC I1307K variant and Treatment-Emergent Neuroendocrine Prostate CancerMinas P Economides, Mari Nakazawa, Jonathan W Lee, et al.
International Journal of Molecular Sciences|July 2, 2021
Pioglitazone Ameliorates Lipopolysaccharide-Induced Behavioral Impairment, Brain Inflammation, White Matter Injury and Mitochondrial Dysfunction in Neonatal RatsJiann-Horng Yeh, Kuo-Ching Wang, Asuka Kaizaki, et al.
Neurochemistry International|January 29, 2020
Interleukin-1 receptor antagonist ameliorates the pain hypersensitivity, spinal inflammation and oxidative stress induced by systemic lipopolysaccharide in neonatal ratsCheng-Ta Hsieh, Yih-Jing Lee, Jonathan W Lee, et al.
Current Research in Neurobiology|January 18, 2024
Intranasal insulin attenuates hypoxia-ischemia-induced short-term sensorimotor behavioral disturbances, neuronal apoptosis, and brain damage in neonatal ratsChirag P Talati, Jonathan W Lee, Silu Lu, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2014
Nephron Deficiency and Predisposition to Renal Injury in a Novel One-Kidney Genetic ModelXuexiang Wang, Ashley C Johnson, Jan M Williams, et al.
Neurochemistry International|April 19, 2024
Neonatal brain inflammation enhances methamphetamine-induced reinstated behavioral sensitization in adult rats analyzed with explainable machine learningKuo-Ching Wang, Norma B Ojeda, Haifeng Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2020
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline <i>BRCA/PALB2</i> MutationEileen M O'Reilly, Jonathan W Lee, Mark Zalupski, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2017
Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinomaMaeve A Lowery, David P Kelsen, Marinela Capanu, et al.
EMBO Molecular Medicine|July 6, 2019
Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistanceEliana Mc Tacconi, Sophie Badie, Giuliana De Gregoriis, et al.
Cancer|January 17, 2018
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinomaEileen M O'Reilly, Jonathan W Lee, Maeve A Lowery, et al.
Pageof 4